What We Do
NeuroTx - developing solutions for sleep
and mental health care
NeuroTx™ is an AI-driven company delivering personalized electroceutical solutions.
Through non-invasive transdermal nerve stimulation, we support targeted neurotransmitter activity and anti-inflammatory pathways.
In collaboration with leading hospitals and medical institutions, we develop medical and wellness devices for managing autonomic symptoms related to depression, mild cognitive impairment, epilepsy, and more.
NeuroTx™ develops its core technologies in close collaboration with Brain Lab™ at the College of Informatics, Korea University.
Brain Lab™ is a world-class neuroscience lab with leading research in electroceuticals, brain–computer interfaces (BCI), and biosignal-based medical AI.
NeuroTx™ devices and algorithms are designed within Brain Lab™’s research environment,
integrating hardware and software development, user adaptability assessment, and neural response validation.
This process ensures our technology is rigorously refined for real-world safety and effectiveness.
Brain Lab™ collaborates with leading medical institutions worldwide, conducting research using real patient data.
This foundation enables NeuroTx™ to develop scientifically grounded, highly reliable technologies—
delivering neuromodulation solutions proven beyond the lab, in real-world settings.
NeuroTx Research Partners
NEWS
Aving News
[CES 2026 Feature Interview] NeuroTx Wins Innovation Award with...
[CES 2026 Feature Interview] NeuroTx Wins Innovation Award with WillSleep, a Side-Effect-Free Sleep Solution.
Money Today
Kakao Ventures Portfolio Company at CES 2026 — NeuroTx Wins...
Seven startups backed by Kakao Ventures will showcase their innovations at CES 2026, held January 6–9 in Las Vegas.
Seoul News
[Hoban Innovation Technology Challenge] Personalized Neural...
NeuroTx develops WillSleep, a wellness device for sleep management, and WillCog, a digital solution designed to support cognitive function.